Antibodies against the Trypanosoma cruzi ribosomal P proteins induce apoptosis in HL-1 cardiac cells

International Journal for Parasitology

Volumn 41, Issue 6, 2011, Pages 635-644

  Levy, Gabriela V ^a   Tasso, Laura M ^a   Longhi, Silvia A ^a   Rivello, Hernán García ^b   Kytö, Ville ^c   Saukko, Pekka ^d   Levin, Mariano J ^a   Gómez, Karina A ^a  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Adrenergic receptor; Anti ribosomal P proteins antibodies; Apoptosis; Cardiomyocytes; Chronic Chagas heart disease; Trypanosoma cruzi

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN G; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 17.2; PEPTIDE; PEPTIDE R13; PROPRANOLOL; PROTEIN BAX; PROTEIN BCL XL; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY C5; SPHINGOLIPID ACTIVATOR PROTEIN 2; UNCLASSIFIED DRUG;

ANTIBODY; APOPTOSIS; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; PARASITE;

ADRENERGIC SYSTEM; ADULT; ANIMAL CELL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CHAGAS DISEASE; CONTROLLED STUDY; CROSS REACTION; FEMALE; HEART MITOCHONDRION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; MOUSE; NONHUMAN; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; APOPTOSIS; CASPASE 3; CELL LINE; CROSS REACTIONS; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; MICE; MIDDLE AGED; MYOCYTES, CARDIAC; PHOSPHOPROTEINS; RECEPTORS, ADRENERGIC, BETA; RIBOSOMAL PROTEINS; SINGLE-CHAIN ANTIBODIES; TRYPANOSOMA CRUZI;

MURINAE; TRYPANOSOMA CRUZI;

EID: 79954686954     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.12.010     Document Type: Article

References (44)

1. Abdelwahid E., Smith G. Apoptosis in chronic heart failure. Int. J. Cardiol. 2007, 114:375.
2. Baba A., Yoshikawa T., Fukuda Y., Sugiyama T., Shimada M., Akaishi M., Tsuchimoto K., Ogawa S., Fu M. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur. Heart J. 2004, 25:1108-1115.
3. Chiale P.A., Ferrari I., Mahler E., Vallazza M.A., Elizari M.V., Rosenbaum M.B., Levin M.J. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001, 103:1765-1771.
4. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., Izzo N.J. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. USA 1998, 95:2979-2984.
5. Communal C., Singh K., Pimentel D.R., Colucci W.S. Noreinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 1998, 98:1329-1334.
6. Elies R., Ferrari I., Wallukat G., Lebesgue D., Chiale P., Elizari M., Rosenbaum M., Hoebeke J., Levin M.J. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J. Immunol. 1996, 157:4203-4211.
7. Ferrari I., Levin M.J., Wallukat G., Elies R., Lebesgue D., Chiale P., Elizari M., Rosembaum M., Hoebeke J. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J. Exp. Med. 1995, 182:59-65.
8. Filipeanu C.M., Zhou F., Lam M.L., Kerut K.E., Claycomb W.C., Wu G. Enhancement of the recycling and activation of beta-adrenergic receptor by Rab4 GTPase in cardiac myocytes. J. Biol. Chem. 2006, 281:11097-11103.
9. Gomez E.B., Medina G., Ballesta J.P., Levin M.J., Tellez-Iñon M.T. Acidic ribosomal P proteins are phosphorylated in Trypanosoma cruzi. Int. J. Parasitol. 2001, 31:1032-1039.
10. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
11. Hernandez C.C., Nascimento J.H., Chaves E.A., Costa P.C., Masuda M.O., Kurtenbach E., Campos De Carvalho A.C., Gimenez L.E. Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease. J. Recept. Signal Transduct. Res. 2008, 28:375-401.
12. Jahns R., Boivin V., Krapf T., Wallukat G., Boege F., Lohse M.J. Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J. Am. Coll. Cardiol. 2000, 36:1280-1287.
13. Jahns R., Boivin V., Schwarzbach V., Ertl G., Lohse M.J. Pathological autoantibodies in cardiomyopathy. Autoimmunity 2008, 41:454-461.
14. Jahns R., Boivin V., Siegmund C., Inselmann G., Lohse M.J., Boege F. Autoantibodies activating human β1-adrenergic receptor are associated with reduced cardiac function in chronic heart failure. Circulation 1999, 99:649-654.
15. Jane-wit D., Altuntas C.Z., Johnson J.M., Yong S., Wickley P.J., Clark P., Wang Q., Popovic Z.B., Penn M.S., Darmon D.S., Perez D.M., Tuohy V.K. Beta1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 2007, 116:399-410.
16. Kang P.M., Isumo S. Apoptosis and heart failure. A critical review of the literature. Circ. Res. 2000, 86:1107-1113.
17. Kaplan D., Ferrari I., Bergami P.L., Mahler E., Levitus G., Chiale P., Hoebeke J., Van Regenmortel M.H., Levin M.J. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 1997, 94:10301-10306.
18. Kytö V., Saraste A., Saukko P., Henn H., Pulkki K., Vuorinen T., Voipio-Pulkki L.M. Apoptosis cardiomyocyte death in fatal myocarditis. Am. J. Cardiol. 2004, 94:746-750.
19. Labovsky V., Smulski C.R., Gómez K.A., Levy G., Levin M.J. Anti-β1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin. Exp. Immunol. 2007, 148:440-449.
20. Lee Y., Gustafsson A.B. Role of apoptosis in cardiovascular disease. Apoptosis 2009, 14:536-548.
21. López Bergami P., Gómez K.A., Levy G.V., Grippo V., Baldi A., Levin M.J. The β1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2β protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition. Clin. Exp. Immunol. 2005, 142:140-147.
22. López Bergami P., Scaglione J., Levin M.J. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J. 2001, 15:2602-2612.
23. Lula J.F., Rocha M.O., Nunes M.C., Ribeiro A.L., Teixeira M.M., Bahia M.T., Talvani A. Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction. Eur. J. Heart Fail. 2009, 11:825-831.
24. Magnusson Y., Wallukat G., Waagstein F., Hjalmarson A., Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the β1-adrenoreceptor with positive chronotropic effect. Circulation 1994, 89:2760-2767.
25. Mahler E., Hoebeke J., Levin M. Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2β protein in patients with chronic Chagas' heart disease. Clin. Exp. Immunol. 2004, 136:527-534.
26. Mahler E., Sepulveda P., Jeannequin O., Liegeard P., Gounon P., Wallukat G., Eftekhari P., Levin M.J., Hoebeke J., Hontebeyrie M. A monoclonal antibody against the immunodominant epitope of the ribosomal P2β protein of Trypanosoma cruzi interacts with the human β1-adrenergic receptor. Eur. J. Immunol. 2001, 31:2210-2216.
27. Masuda M.O., Levin M., De Oliveira S.F., Dos Santos Costa P.C., Bergami P.L., Dos Santos Almeida N.A., Pedrosa R.C., Ferrari I., Hoebeke J., Campos de Carvalho A.C. Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J. 1998, 12:1551-1558.
28. Muller S., Couppez M., Briand J.P., Gordon J., Sautiere P., van Regenmortel M.H. Antigenic structure of histone H2B. Biochem. Biophys. Acta 1985, 827:235-246.
29. Nattel S. Inappropriate sinus tachycardia and beta-receptor autoantibodies: a mechanistic breakthrough?. Heart Rhythm 2006, 3:1187-1188.
30. Nishida K., Otsu K. Cell death in heart failure. Circ. J. Suppl. A 2008, 17-21.
31. Peter J.C., Eftekhari P., Billiald P., Wallukat G., Hoebeke J. ScFv single chain antibody variable fragment as inverse agonist of the beta2-adrenergic receptor. J. Biol. Chem. 2003, 278:36740-36747.
32. Peter J.C., Wallukat G., Tugler J., Maurice D., Roegel J.C., Briand J.P., Hoebeke J. Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments. J. Biol. Chem. 2004, 279:55697-55706.
33. Remião F., Carmo H., Carvalho F.D., Bastos M.L. Inhibition of glutathione reductase by isoproterenol oxidation products. J. Enzyme Inhib. 2000, 15:47-61.
34. Resende R.R., Adhikari A. Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun. Signal. 2009, 27:7-20.
35. Rosenbaum M.B., Chiale P.A., Schejtman D., Levin M., Elizari M.V. Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' heart disease. J. Cardiovasc. Electrophysiol. 1994, 5:367-375.
36. Rossi M.A., Souza A.C. Is apoptosis a mechanism of cell death of cardiomyocytes in chronic chagasic myocarditis?. Int. J. Cardiol. 1999, 68:325-331.
37. Smulski C., Labovsky V., Levy G., Hontebeyrie M., Hoebeke J., Levin M.J. Structural basis of the crossreaction between an antibody to the Trypanosoma cruzi ribosomal P2β protein and the human β1 adrenergic receptor. FASEB J. 2006, 20:1396-1406.
38. Staudt Y., Mobini R., Fu M., Felix S.B., Kühn J.P., Staudt A. 1-adrenoreceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur. J. Pharmacol. 2003, 466:1-6.
39. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi Infection. Trends Parasitol. 2002, 18:262-265.
40. Tostes S., Rocha-Rodrigues D.B., de Araujo Pereira G., Rodrigues V. Myocardiocyte apoptosis in heart failure in chronic Chagas's disease. Int. J. Cardiol. 2005, 99:233-237.
41. Wallukat G., Fu M.L., Magnusson Y., Hjalmarson A., Hoebeke J., Wollenberger A. Agonistic effects of anti-peptide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization. Blood Press Suppl. 1996, 3:31-36.
42. World Health Organization, 2002. Control of Chagas disease. WHO Technical Report Series 905, p. 109.
43. Zingales B., Andrade S.G., Briones M.R.S., Campbell D.A., Chiari E., Fernandes O., Guhl F., Lages-Silva E., Macedo A.M., Machado C.R., Miles M.A., Romanha A.J., Sturm N.R., Tibayrenc M., Schijman A.G. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz. 2009, 104:1051-1054.
44. 2+/calmodulin II. J. Clin. Invest. 2003, 111:617-625.